Filter
7145
Filtered Results: 7145
Text search:
Monitoring
and
Evaluation
Featured
Recommendations
659
New Publications
2083
Language
Document type
No document type
4343
Studies & Reports
977
Guidelines
900
Manuals
380
Strategic & Response Plan
291
Training Material
92
Fact sheets
85
Situation Updates
45
Resource Platforms
11
Infographics
11
Brochures
8
App
1
Online Courses
1
Countries / Regions
India
289
Global
268
Kenya
231
Ethiopia
173
Uganda
156
Nepal
154
Sierra Leone
147
South Africa
146
Nigeria
138
Western and Central Europe
130
Liberia
129
Rwanda
118
Malawi
111
Zambia
109
Myanmar / Burma
109
Tanzania
108
Ghana
105
Africa
96
Bangladesh
95
Latin America and the Carribbean
86
Syria
73
Ukraine
71
Philippines
65
Congo, Democratic Republic of
64
Namibia
61
Eastern Europe
51
Lesotho
50
Cambodia
48
Indonesia
48
Zimbabwe
46
Senegal
44
South–East Asia Region
44
Haiti
42
Guinea
41
West and Central Africa
40
South Sudan
39
Mozambique
39
Germany
38
Botswana
37
East and Southern Africa
37
Middle East and North Africa
36
Burkina Faso
32
Asia
30
Russia
30
Cameroon
27
Brazil
26
Eastern Europe and Central Asia
24
Benin
23
Yemen
22
Pakistan
21
Eswatini/ Swaziland
21
Jordan
20
Afghanistan
20
Lebanon
17
Western Pacific Region
16
Venezuela
16
Mali
15
Sudan
15
Iraq
14
Madagascar
14
USA
13
Somalia
13
Thailand
13
Colombia
12
Laos
12
Vietnam
12
Tajikistan
11
Albania
10
Paraguay
9
Turkey
8
Central African Republic
8
Angola
8
Georgia
8
China
7
Argentina
7
Peru
7
Sri Lanka
7
Moldova
7
Iran
7
Côte d’Ivoire / Ivory Coast
6
Libya
6
Southern Africa
6
Kyrgyzstan
6
Portugal
6
Saudi Arabia
5
Niger
5
Egypt
5
Gambia
5
North Macedonia
5
Bhutan
5
Timor Leste/ East Timor
5
Togo
4
Chad
4
Papua New Guinea
4
Burundi
4
Mexico
4
Chile
4
Palestine
4
Armenia
4
North America
4
Spain
4
Morocco
3
Mauritania
3
Croatia
3
Honduras
3
Canada
3
Qatar
3
Estonia
3
Kazakhstan
3
Turkmenistan
3
Japan
3
United Kingdom
3
Bosnia and Herzegovina
3
Guinea-Bissau
2
Singapore
2
Vanuatu
2
Serbia
2
Ecuador
2
Bolivia
2
Greece
2
North Korea
2
Italy
2
Congo-Brazzaville
2
Romania
2
Lithuania
2
Jamaica
2
France
2
Mauritius
2
Tunisia
2
Azerbaijan
2
Israel
2
Malaysia
1
Ireland
1
Dominican Republic
1
Hungary
1
El Salvador
1
Guatemala
1
Nicaragua
1
Fiji
1
Solomon Islands
1
Poland
1
Djibouti
1
Bulgaria
1
Uruguay
1
Denmark
1
Maldives
1
Norway
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
2810
Clinical Guidelines
558
Public Health
409
Key Resources
394
Women & Child Health
366
Capacity Building
138
Pharmacy & Technologies
72
Toolboxes
HIV
553
Mental Health
449
COVID-19
430
TB
393
Disability
275
Rapid Response
216
AMR
216
Planetary Health
215
Ebola
202
Caregiver
185
Conflict
184
NTDs
158
NCDs
119
Pharmacy
114
Natural Hazards
113
Refugee
107
Global Health Education
107
Health Financing Toolbox
56
Specific Hazards
49
Polio
41
Cholera
38
Zika
37
Social Ethics
8
Typhoon
5
Health Financing
2
South Sudan
1
Jin et al. Military Medical Research (2020) 7:4 https://doi.org/10.1186/s40779-020-0233-6
Position Article und Guideline
As of 21 May 2020, 4.8 million confirmed cases of Coronavirus disease 2019 (COVID-19) have been reported globally. In South America, COVID-19 was first detected on 26 February 2020, when Brazil confirmed a case in São Paulo.
Overview of technologies for the treatment of infectious and sharp waste from health care facilities
This document provides an overview of specific health care waste technologies for the treatment of solid infectious and sharp waste. For each technology, details of its operation, effects on the environment ... health, requirements for installation, capacities for treating waste, examples of consumables and advantages and disadvantages are described. The document is designed for health care facility administrators and planners, WASH and infection prevention control staff, national planners, donors and partners.
The availability of water, sanitation and hygiene (WASH) services in health care facilities, especially in maternity and primary-care settings where they are often absent, supports core aspects of q...
Modelling the health impacts of disruptions to essential health services during COVID-19 Module 1
Several epidemiological models have been created to assess the potential impact of disruptions to essential health services caused by COVID-19 on morbidity a... mortality from conditions other than COVID-19 illness. This guide presents models that have been used to assess these indirect impacts. The effects have been studied in various settings, using a variety of models.
The guide is intended for people who need to understand what the models say, their construction and their underlying assumptions, or need to use models and their outcomes for planning and programme development and to support policy decisions for a country or region.
The standards for the care of small and sick newborns in health facilities define, standardize and mainstream inpatient care of small and sick newb...
The OIE has been working on the AMR issue for a long
time. In undertaking its role as a standard- setting organisation*
for animal health, including zoonoses, the OIE has developed
a wide range of international standards on antimicrobial
agents, in particular on responsible ... prudent use.
These standards are regularly reviewed and updated
through the transparent and inclusive process of expert
advice and member consultation before presentation for
adoption to the World Assembly of Delegates from our
180 Member Countries each year. The OIE also works with
its Member countries in a comprehensive and continuous
capacity building process for their Veterinary Services.
Consultancy Report May 2022
Despite the continuing war in Ukraine, the Government is preparing for the country’s recovery and reconstruction. Given the magnitude of the attacks on the health infrastructure and consequent dis...
Countries are making progress toward the global goal of 95% of people living with HIV knowing their status by 2025. However, considerable gaps remain in achieving these goals globally. Men in high HIV burden settings and men from key populations in ...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, ... the policies and strategies implemented by countries and health systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The standards define 10 key competencies for health and care workers to support self-care in their clinical practice as well as the specific, measurable behaviours that demonstrate those competencies, focusing on people-centredness; decision-making;...
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Di...
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – along with mental health, cause nearly...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, ... the policies and strategies implemented by countries and health systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and...
This document provides information for WHO Member States, particularly low-income and middle-income countries, to strengthen preparedness and response plans with regard to the social ... mental health consequences of biological and chemical attacks.
